Children with and without multiple sclerosis have differences in gut bacteria

In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease. Certain types of bacteria were either more or less abundant in children with multiple sclerosis. In particular, there was an association between multiple sclerosis and an increase in gut bacteria that have been linked to inflammation and a decrease in gut bacteria that are considered anti-inflammatory.

A better understanding of 's role in may identify novel drug targets and pathways to .

"While these findings are preliminary, they are intriguing. We also observed some similarities between our findings and other emerging gut microbiota studies in multiple sclerosis; whether these indicate a 'gut signature' of multiple sclerosis or of broader autoimmune disease remains to be determined," said Professor Helen Tremlett, lead author of the European Journal of Neurology study.

"We also found differences in the gut microbiota composition between those children taking a disease-modifying drug for their disease compared with those who were not. This finding warrants further study."

Explore further

Exploring the gut-brain connection for insights into multiple sclerosis

More information: H. Tremlett et al, Gut microbiota in early pediatric multiple sclerosis: a case−control study, European Journal of Neurology (2016). DOI: 10.1111/ene.13026
Provided by Wiley
Citation: Children with and without multiple sclerosis have differences in gut bacteria (2016, May 16) retrieved 28 October 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors